Trials / Conditions / Neoadjuvant Chemoradiotherapy

Neoadjuvant Chemoradiotherapy

11 registered clinical trials studyying Neoadjuvant Chemoradiotherapy — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Predicting Pathological Complete Response in Rectal Cancer Using Machine Learning NCT07509632	Peking University People's Hospital	—
Recruiting	Oral Immunonutrition Therapy to Reduce Acute Toxicity After Neoadjuvant Chemoradiotherapy Pancreatic Cancer Pa NCT06736678	Sun Yat-sen University	N/A
Unknown	Predicting the Efficacy and Prognosis of Rectal Cancer Patients Based on ctDNA-MRD Technology NCT05969938	WeiWei Xiao	—
Unknown	Neoadjuvant Sintilimab Plus Chemoradiotherapy for Locally Advanced Adenocarcinoma of Esophagogastric Junction NCT06250894	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Phase 2
Unknown	THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI Guided Radiotherapy NCT04815694	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	N/A
Completed	Study on the Applicability of CCR Criteria in Rectal Cancer NCT06794099	Peking University Cancer Hospital & Institute	—
Completed	Different Radiation Dose of Neoadjuvant Chemoradiation for Resectable Thoracic Esophageal Squamous Carcinoma NCT03381651	Zhejiang Cancer Hospital	N/A
Active Not Recruiting	Statistical Analysis Plan for the SANO-trial: Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Active NCT05953181	Erasmus Medical Center	N/A
Unknown	The Analysis of Immuno-Nutrition Index in Advanced Gastric Cancer Receiving Preoperative Treatments NCT03493880	Peking University	—
Completed	Observational Study on the Patients With Rectal Cancer NCT02312284	Chinese Academy of Medical Sciences	—
Completed	Outcomes of Resection at Different Times Between the End of Neoadjuvant Treatment and Surgery NCT04013347	Campus Bio-Medico University	—